Klingenstein Fields & CO LP Novartis Ag Transaction History

Klingenstein Fields & CO LP

  • $2.48 Billion
  • Q3 2024

A detailed history of Klingenstein Fields & CO LP transactions in Novartis Ag stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 6,797 shares of NVS stock, worth $668,484. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,797
Previous 6,797 -0.0%
Holding current value
$668,484
Previous $723,000 8.02%
% of portfolio
0.03%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$92.57 - $107.37 $22,772 - $26,413
-246 Reduced 3.49%
6,797 $723,000
Q1 2024

Apr 29, 2024
SELL
$95.27 - $108.47 $161,959 - $184,399
-1,700 Reduced 19.44%
7,043 $681,000
Q4 2023

Feb 01, 2024
BUY
$92.27 - $101.54 $46,135 - $50,770
500 Added 6.07%
8,743 $882,000
Q1 2023

Apr 28, 2023
SELL
$80.03 - $92.81 $78,829 - $91,417
-985 Reduced 10.67%
8,243 $758,000
Q4 2022

Feb 02, 2023
SELL
$75.55 - $92.52 $1,057 - $1,295
-14 Reduced 0.15%
9,228 $837,000
Q2 2022

Aug 01, 2022
BUY
$80.52 - $93.75 $79,312 - $92,343
985 Added 11.93%
9,242 $781,000
Q1 2022

Apr 27, 2022
SELL
$80.11 - $90.62 $97,894 - $110,737
-1,222 Reduced 12.89%
8,257 $725,000
Q4 2021

Jan 31, 2022
SELL
$79.7 - $88.13 $23,192 - $25,645
-291 Reduced 2.98%
9,479 $829,000
Q3 2021

Oct 26, 2021
BUY
$81.78 - $95.14 $80,798 - $93,998
988 Added 11.25%
9,770 $799,000
Q2 2021

Jul 26, 2021
SELL
$85.24 - $94.15 $10,228 - $11,298
-120 Reduced 1.35%
8,782 $801,000
Q4 2020

Feb 02, 2021
BUY
$78.07 - $94.43 $15,613 - $18,886
200 Added 2.3%
8,902 $841,000
Q4 2019

Feb 04, 2020
SELL
$84.35 - $95.37 $4,723 - $5,340
-56 Reduced 0.64%
8,702 $824,000
Q3 2019

Nov 01, 2019
SELL
$85.54 - $94.26 $98,371 - $108,399
-1,150 Reduced 11.61%
8,758 $761,000
Q2 2019

Aug 12, 2019
SELL
$75.4 - $92.8 $4,976 - $6,124
-66 Reduced 0.66%
9,908 $905,000
Q1 2019

Apr 29, 2019
SELL
$75.32 - $86.15 $1,506 - $1,723
-20 Reduced 0.2%
9,974 $959,000
Q3 2018

Nov 01, 2018
SELL
$66.94 - $77.43 $33,470 - $38,715
-500 Reduced 4.76%
9,994 $861,000
Q2 2018

Jul 26, 2018
SELL
$64.91 - $73.36 $65,883 - $74,460
-1,015 Reduced 8.82%
10,494 $793,000
Q4 2017

Jan 30, 2018
SELL
$72.33 - $77.64 $43,398 - $46,584
-600 Reduced 4.95%
11,509 $966,000
Q3 2017

Nov 01, 2017
BUY
$74.14 - $77.27 $897,761 - $935,662
12,109
12,109 $1.04 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Klingenstein Fields & CO LP Portfolio

Follow Klingenstein Fields & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email